Expression of Myeloid-Related Protein-8 and -14 in Patients With Acute Kawasaki Disease

Journal of the American College of Cardiology

Volumn 48, Issue 6, 2006, Pages 1257-1264

  Hirono, Keiich ^a   Foell, Dirk ^b   Xing, Yanlin ^a   Miyagawa Tomita, Sachiko ^c   Ye, Fei ^a   Ahlmann, Martina ^b   Vogl, Thomas ^b   Futatani, Takeshi ^a   Rui, Chen ^a   Yu, Xianyi ^a   Watanabe, Kazuhiro ^a   Wanatabe, Sayaka ^a   Tsubata, Shinichi ^a   Uese, Keiichiro ^a   Hashimoto, Ikuo ^a   Ichida, Fukiko ^a   Nakazawa, Makoto ^c   Roth, Johannes ^b   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MYELOID RELATED PROTEIN 14; MYELOID RELATED PROTEIN 8; PROTEIN S 100; UNCLASSIFIED DRUG;

ARTICLE; CELL SECRETION; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOGENESIS; VALIDATION PROCESS;

ACUTE DISEASE; BLOOD CELLS; CALGRANULIN A; CALGRANULIN B; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; GRANULOCYTES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33748437572     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.02.077     Document Type: Article

References (23)

1. Kato H., Sugiyama T., Akagi T., et al. Long-term consequences of Kawasaki disease. Circulation 94 (1996) 1379-1385
2. Dajani A.S., Taubert K.A., Gerber M.A., et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 87 (1993) 1776-1780
3. Hashino K., Ishii M., Iemura M., Akagi T., and Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 43 (2001) 211-217
4. Fujiwara H., and Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 61 (1978) 100-104
5. Naoe S., Shibuya K., Takahashi K., et al. Pathological observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol Young 1 (1991) 212-220
6. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33 (1991) 805-810
7. Niwa K., Aotsuka H., Hamada H., et al. Low platelet counts: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease. Coron Artery Dis 6 (1995) 857-864
8. Roth J., Vogl T., Sorg C., and Sunderkötter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 24 (2003) 155-158
9. Frosch M., Vogl T., Seeliger S., et al. Expression of myeloid-related protein 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 48 (2003) 2622-2626
10. Foell D., and Roth J. Proinflammatory S100-proteins in arthritis and autoimmune disease. Arthritis Rheum 50 (2004) 3762-3771
11. Robinson M.J., Tessier P., Poulsom R., and Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparin sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277 (2002) 3658-3665
12. Srikrishna G., Panneerselvam K., Westphal V., et al. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 166 (2001) 4678-4688
13. Viemann D., Strey A., Janning A., et al. Myeloid-related protein 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105 (2005) 2955-2962
14. Shulman S.T., Inocencio J., and Hirsch R. Kawasaki disease. Pediatr Clin North Am 42 (1995) 1205-1222
15. Roth J., Burwinkel F., van den Bos C., et al. MRP-8 and -14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 15 (1993) 1875-1883
16. Futatani T., Miyawaki T., Tsukada S., et al. Deficient expression of Bruton tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91 (1998) 595-602
17. Liu W., and Saint D.A. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302 (2002) 52-59
18. Yu X., Hirono K.I., Ichida F., et al. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res 55 (2004) 688-694
19. Nakatani K., Takeshima S., Tsujimoto H., et al. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 131 (2003) 536-540
20. Terai M., Jibiki T., Harada A., et al. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 65 (1999) 566-572
21. Jun A., Toshiaki J., Seiji N., et al. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 174 (2005) 5837-5845
22. Rammes A., Roth J., Goebeler M., et al. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272 (1997) 9496-9502
23. Zaitsu M., Hamasaki Y., Tashiro K., et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 181 (2000) 1101-1109